Nuzenio

Ratio Therapeutics

Ratio Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Timeline

Sun, 09 Aug 2026 00:34:03 GMTLong term debt to total equity ratio of BLOSSOMHILL THERAPEUTICS INC – NASDAQ:BLSM - TradingView
Wed, 05 Aug 2026 11:04:15 GMTRatio Therapeutics Raises $70 Million Series C To Advance Radiopharmaceutical Pipeline - Pulse 2.0
Mon, 03 Aug 2026 11:58:46 GMTRatio Therapeutics raises $70m to expand radiopharmaceutical manufacturing - Manufacturing Chemist
Mon, 03 Aug 2026 11:31:33 GMTRatio Therapeutics raises $70 million for radiopharma pipeline - The Pharma Letter
Mon, 03 Aug 2026 09:40:20 GMTCatalio Capital Joins $70M Series C for Oncology Startup Ratio Therapeutics - citybiz
Mon, 03 Aug 2026 08:49:57 GMTRatio Therapeutics secures $70m in Series C funds for cancer radiotherapy - Pharmaceutical Technology

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ratio Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.